6505--Oseltamivir (VA-24-00009464)
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 36E79723R0039
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs National Acquisition Center intends to issue solicitation number 36E79723R0039 to procure oseltamivir suspension and capsules from a single contractor for distribution to VA, DOD, BOP and IHS customers. The contract will have a one year base period and four one-year option periods and require the contractor to provide an uninterrupted supply of oseltamivir in 30mg, 45mg and 75mg capsule quantities totaling over 100 million annually as well as over 34,000 bottles of 6mg/ml suspension per year. Questions regarding this pre-solicitation notice must be submitted to the point of contact by October 23, 2023.
There is no set-aside designation for this requirement. The NAICS code is 325412 and PSC code is 6505. No incumbent or current contractors were named but the total estimated annual quantities of oseltamivir equate to over $10 million in sales. Key details include specific annual estimated requirements by dosage form and package size ranging from 10,000 bottles of 30mg capsules to over 81 million bottles of 75mg capsules.
Notice text
The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79723R0039 for an unrestricted procurement for Oseltamivir Suspension and Capsules for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC or UPC number that is unique to the offeror. Solicitation #36E79723R0039 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 9, 2023, with a tentative closing date of October 23, 2023. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: https://sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Youlanda Duggar. Questions can be e-mailed to: Youlanda.Duggar@va.gov.
The estimated annual requirements are as follows:
ITEM DESCRIPTIONÂ PKG SIZE TOTAL EST ANNUAL USAGE
(Per Bottle)Â (Bottles)Â
1 OSELTAMIVIR PO4 30MG CAP 10 Caps 10,488
2 OSELTAMIVIR PO4 45MG CAP 10 Caps 2,123
3 OSELTAMIVIR PO4 75MG CAP 10 Caps 81,760
4 OSELTAMIVIR PO4 6MG/ML SUSP 60mL 34, 341
For line items 1 through 3 (capsules), product may be provided either in blister packs or bottles. If provided in bottles, the bottles must meet Unit of Use size requirements. All unit of use bottles must contain a child proof closure (safety cap) and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and maximum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 .
Glass Bottles are not acceptable for line items 1 through 3, but are acceptable for line item 4 (suspension).
Files
| File | Type | Posted |
|---|---|---|
| 36E79723R0039_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Oseltamivir Phosphate Capsules and Suspension | Award Notice | |
| 6505--Oseltamivir (VA-24-00009464) | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| 6505--Sacubitril/Valsartan Tablets (VA-27-00014055) | National Acquisition Center | No set-aside | |
| 6505--766-27-1-400-0021 -Charleston CMOP CALCIUM 500MG/VIT D 500UNIT CHEW TAB 90CT -(VA-27-00014312) | Veterans Integrated Service Network 15 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity